# Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer

> **NCT02527824** · PHASE2 · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 31 (estimated)

## Conditions studied

- Biliary Tract Neoplasm

## Interventions

- **DRUG:** Oxaliplatin, Irinotecan, S-1

## Key facts

- **NCT ID:** NCT02527824
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-08
- **Final completion:** 2017-09
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2017-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02527824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02527824, "Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02527824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*